Home › Funds › Sofinnova Investments, Inc. › NRIX
Sofinnova Investments, Inc. position in NRIX
NURIX THERAPEUTICS INC · Health Care
Sofinnova Investments, Inc. reported holding 524,098 shares of NRIX (NURIX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$12.7M, representing 0.68% of its reported portfolio and ranking #34 among its reported holdings. Sofinnova Investments, Inc. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s NRIX position evolved
Sofinnova Investments, Inc. first disclosed a stake in NRIX in Q2 2026 at 524,098 shares (US$12.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 524.10K | $12.71M | New |
About NRIX and 13F data
NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NRIX
- Vestal Point Capital, LP 8.05M sh · $195.29M · Q2 2026
- Deep Track Capital, LP 7.74M sh · $187.69M · Q2 2026
- Rubric Capital Management LP 7.23M sh · $175.35M · Q2 2026
- BAKER BROS. ADVISORS LP 4.66M sh · $113.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.32M sh · $104.81M · Q2 2026
- Redmile Group, LLC 4.07M sh · $98.83M · Q2 2026
- GENERAL ATLANTIC, L.P. 3.03M sh · $73.56M · Q2 2026
- Trails Edge Capital Partners, LP 1.57M sh · $38.17M · Q2 2026
- Soleus Capital Management, L.P. 1.47M sh · $35.54M · Q2 2026
- BRAIDWELL LP 1.29M sh · $31.22M · Q2 2026
- Kynam Capital Management, LP 1.19M sh · $28.98M · Q2 2026
- Affinity Asset Advisors, LLC 967.62K sh · $23.47M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held NRIX?
Sofinnova Investments, Inc. has disclosed NRIX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Sofinnova Investments, Inc.'s current position in NRIX?
As of Q2 2026, Sofinnova Investments, Inc. holds 524.10K shares of NRIX (NURIX THERAPEUTICS INC), valued at $12.71M, representing 0.68% of its reported portfolio and ranking #34.
Has Sofinnova Investments, Inc. been buying or selling NRIX?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in NRIX.
Which other funds hold NRIX?
Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.